Cite
HARVARD Citation
Dong, X. et al. (2022). Hybrid M13 bacteriophage-based vaccine platform for personalized cancer immunotherapy. Biomaterials. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dong, X. et al. (2022). Hybrid M13 bacteriophage-based vaccine platform for personalized cancer immunotherapy. Biomaterials. p. . [Online].